QUARRYMEN & CO INC has a total of 15 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and Hong Kong. Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are POWDERJECT VACCINES INC, PEPTIMED INC and OXXON THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | Hong Kong | 3 | |
#4 | Republic of Korea | 3 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Medical technology | |
#5 | Organic fine chemistry | |
#6 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Special macromolecular compounds | |
#5 | Peptides | |
#6 | Artificial flowers, wigs and masks | |
#7 | Syringes | |
#8 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Yamashita Yasuhiro | 6 |
#2 | Ueda Minoru | 6 |
#3 | Yoshida Shojiro | 4 |
#4 | Suzuki Miho | 4 |
#5 | Hatano Ken | 4 |
#6 | Yasuhiro Yamashita | 3 |
#7 | Shojiro Yoshida | 2 |
#8 | Miho Suzuki | 2 |
#9 | Ken Hatano | 2 |
#10 | Hiroshi Hochi | 1 |
Publication | Filing date | Title |
---|---|---|
EP3384934A1 | Targeted shell for use in drug delivery system utilizing carbosilane dendrimer | |
EP3372681A1 | Immortalized stem cells, and method for producing same | |
KR20160120726A | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as acte ingredient |